Dana–Farber Cancer Institute
Dana–Farber Cancer Institute is a comprehensive cancer treatment and research center in Boston, Massachusetts. It is a principal teaching affiliate of Harvard Medical School, and a founding member of Dana-Farber/Harvard Cancer Center, which is a Comprehensive Cancer Center designated by the National Cancer Institute.
History[edit]
The Dana–Farber Cancer Institute was founded in 1947 by Sidney Farber, a pathologist at Boston Children's Hospital, as the Children's Cancer Research Foundation. The institute was renamed in 1983 in honor of its founder and the philanthropist Charles A. Dana.
Research and Treatment[edit]
Dana–Farber Cancer Institute is known for its research in cancer biology, cancer immunology, and cancer genetics. The institute also provides adult and pediatric care to patients at its Jimmy Fund Clinic, named for the Jimmy Fund, a charity that supports the institute.
Affiliations[edit]
Dana–Farber is part of a comprehensive cancer treatment network, including the Brigham and Women's Cancer Center and Boston Children's Hospital. These affiliations allow the institute to provide a full range of cancer treatment services, from surgery and radiation therapy to clinical trials and genetic counseling.
Notable Achievements[edit]
Dana–Farber researchers have made numerous significant contributions to the understanding and treatment of cancer. These include the development of combination chemotherapy and targeted therapies for various types of cancer.
See Also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
-
Dana-Farber Cancer Institute logo
